WESTMORELAND, JAMAICA / ACCESSWIRE / August 31, 2020 / Virtudes Labs, Inc. slated to be the first vertically-integrated hemp producer and processor of high-grade CBD oil from Jamaica farms announced today that it can now accept online investments from non-accredited or ordinary investors on the Fundanna platform here: https://fundanna.com/equity/offer-summary/VirtudesLabs. Industry companies and accredited investors who wish to inquirer regarding strategic partnerships, joint ventures, or investing in Virtudes can contact Farrah Zargaran, COO directly at (972) 806 – 2688 or email@example.com.
Virtudes is slated to be the first vertically integrated hemp producer and processor of high-grade CBD oil from Jamaican farms. Owned by American shareholders, Virtudes is incorporated and registered in Jamaica. The Company recently acquired over 100 acres of land in Jamaica and is expected to have its first hemp crop during 2020.
Hemp grown in lush Jamaican climate is the foundation for an organic and natural product that we audaciously aim to provide to the world. From seed to sale, we pledge to produce top-quality cannabis outputs in Jamaican farms with the integration of traditional and modern cultivation styles. The year-round sunshine and steady rainfall create an ideal environment for flowers to produce industry-leading, outdoor-grown medical cannabis.
As a global company, Virtudes is navigating a movement towards establishing credibility and value to one of the world’s more useful plants. With strong medicinal benefits, Cannabis-sativa (commonly known as hemp), is breaking down boundaries within every international industry.
At the intersection of experienced farming practices and centuries of cannabis cultivation knowledge, Virtudes is prepared to provide a high-end cannabis product that will also bring value back into its community. Virtudes is fully dedicated to being involved in the extensive research and development of the benefits and advancements of cannabis plants and their byproducts for both daily and medicinal health.
Virtudes and www.virtudescompany.com are operated by Virtudes Labs, Inc., investment opportunities in the Reg CF offering are not a public offering, are private placements, are subject to long hold periods, are illiquid investments and investors must be able to afford the loss of their entire principal. There is no guarantee that Virtudes will register its shares with the SEC or any stock exchange. Offers to buy or sell any security can only be made through official offering and subscription documents that contain important information about risks, fees, and expenses. You should conduct your own due diligence including reviewing in detail the Offering Circular and consultation with a financial advisor, attorney, accountant, or other professional that can help you to understand the risks associated with the investment opportunity.
This release may contain forward-looking statements regarding Virtude’s projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as “expected,” “anticipated,” “projected” and “forecasted.” These statements also include estimates of the pace of customer adoption of the company’s products, engineering developments and prototype capabilities. Please be advised that such statements are intentions or estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company, or that the company will be able to consummate its planned goals (including without limitation, a public listing of its securities). Forward-looking statements may be based on management assumptions that prove to be wrong. The Company’s predictions may not be realized for a variety of reasons, including due to inability to raise a sufficient amount of funds, a lack of marketability for the company’s securities, failure of business operations, competition, customer sales cycles, and engineering or technical issues, among others. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.
Virtudes Labs, Inc.
Farrah Zargaran, COO
(972) 806 – 2688